EFFICACY OF UPADACITINIB ON LUMINAL STENOSIS IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE: A POST HOC ANALYSIS OF PHASE 3 STUDIES

Walter Reinisch  ¹     Raja Atreya  ²     Vipul Jairath  ^{3, 4}     Julian Panés  ⁵     Shuhei Hosomi  ⁶     Maria T. Abreu  ⁷     Florian Rieder  ⁸     Valencia Remple  ⁹     Elena Marced  ⁹     Elena Dubcenco  ⁹     Samuel Anyanwu  ⁹     Andrew Garrison  ⁹     Jean-Frédéric Colombel  ^10    
1 Medical University of Vienna, Vienna, Austria
² Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany
³ Western University, London, Canada
⁴ Alimentiv, London, Canada
⁵ Hospital Clínic Barcelona, Barcelona, Spain
⁶ Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan
⁷ University of Miami Miller School of Medicine, Miami, United States
⁸ Cleveland Clinic Foundation, Cleveland, United States
⁹ AbbVie Inc., North Chicago, United States
¹⁰ Icahn School of Medicine at Mount Sinai, New York, United States

Topic
IBD

Session
Medical therapy of IBD: Facts and challenges (Posters)

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)